Search

Meet Memorial Sloan Kettering senior vice president Cynthia McCollum, who led MSK's response to the COVID-19 pandemic.

… Friday, April 2, 2021 Summary Cynthia McCollum , Senior Vice President, Hospital Administration, has served as the Incident Commander for the Hospital Incident Command System (HICS), overseeing MSK’s response to the COVID-19 pandemic, since April 2020. Given her wide-ranging interests and experiences

New MSK research measures unscheduled healthcare interactions in multiple myeloma patients receiving T cell redirection therapies; investigates oral bacteria’s link to gut microbiota depletion with implications for cancer patients; and shows how a universal opt-out approach could help more cancer patients quit smoking.

… Friday, May 10, 2024 New research from Memorial Sloan Kettering Cancer Center (MSK) measures unscheduled healthcare interactions in multiple myeloma patients receiving T cell redirection therapies; investigates oral bacteria’s link to gut microbiota depletion with implications for cancer patients; and

In this Q&A, Memorial Sloan Kettering chemist Derek Tan discusses why natural products offer inspiration for the development of new drugs.

… Monday, September 16, 2013 Summary In this Q&A, Memorial Sloan Kettering chemist Derek Tan discusses why natural products offer inspiration for the development of new drugs. Derek Tan , a chemist and a member of the Sloan Kettering Institute’s Molecular Pharmacology and Chemistry Program , is searching

Memorial Sloan Kettering Cancer Center (MSK) announced that Cardinale Smith, MD, PhD, has joined the institution as the inaugural Chief Medical Officer (CMO).

… Thursday, May 29, 2025 Memorial Sloan Kettering Cancer Center (MSK) announced that  Cardinale Smith, MD, PhD , has joined the institution as the inaugural Chief Medical Officer (CMO). In this role, Dr. Smith oversees clinical quality, patient safety, regulatory compliance, and works with faculty and

Proton beam radiotherapy resulted in similar oncologic outcomes with less toxicity and improved quality of life than photon beam radiotherapy in patients with head and neck cancers, according to results of an MSK-led clinical trial presented today at the 2025 American Society for Radiation Oncology Annual Meeting.

… Monday, September 29, 2025 Proton beam radiotherapy resulted in similar oncologic outcomes with less toxicity and improved quality of life than photon beam radiotherapy (intensity modulated radiotherapy, IMRT) in patients with head and neck cancers, according to results of an MSK-led clinical trial presented

A new study from Memorial Sloan Kettering’s (MSK) Marcel van den Brink— in collaboration with Jarrod Dudakov, PhD, at the Fred Hutchinson Cancer Center — has identified a molecule that promotes thymus regeneration. The results could pave the way toward treatments that could one day help rejuvenate an aging or damaged thymus. For more information or to speak with an expert, contact Rebecca Williams at [email protected].

… Friday, January 12, 2018 Bottom line: A new study from Memorial Sloan Kettering’s (MSK) Marcel van den Brink— in collaboration with Jarrod Dudakov, PhD , at the Fred Hutchinson Cancer Center — has identified a molecule that promotes thymus regeneration. The results could pave the way toward treatments

Charles L. Sawyers, Chair of the Human Oncology and Pathogenesis Program, has been awarded the 2009 Dorothy P. Landon Prize for Translational Cancer Research from the American Association for Cancer Research.

… Friday, May 1, 2009 Summary Charles L. Sawyers, Chair of the Human Oncology and Pathogenesis Program, has been awarded the 2009 Dorothy P. Landon Prize for Translational Cancer Research from the American Association for Cancer Research. Charles L. Sawyers , Chair of the Human Oncology and Pathogenesis

Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments:

… Thursday, October 3, 2024 Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments:   Yasmin Khakoo Received the 2024 American Medical Women’s Association INSPIRE Award and Elected to the Child Neurology Society Board of Directors Yasmin Khakoo, MD, FAAN, FACS

Learn about important advances in the treatment of pancreatic cancer.

… Thursday, June 5, 2025 Many people have questions about pancreatic cancer and its prognosis. MSK surgeon-scientist and pancreatic cancer expert Vinod Balachandran, MD, discusses why the disease is so hard to detect, what the latest treatment options are, and how promising research may improve survival

The Cycle for Survival community, along with founding partner, Equinox, achieves a historic fundraising milestone, fueling rare cancer research at Memorial Sloan Kettering.

… Thursday, April 28, 2022 Cycle for Survival, the movement to beat rare cancers, made history by surpassing $300 million in total funds raised through its signature stationary-cycling events. Since 2007, more than 1 million participants worldwide, including patients, caregivers, survivors, as well as